No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
www.ak-medical.netNo one on the platform currently holds 1789.HK.
No tracked institution reports a position in 1789.HK as of their last filing.
No one on the platform has traded 1789.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 12.0% | 9.4% | 26.1% | — | — | — |
| Rev. Growth % | 10.1% | 7.4% | ||||
| Profit Margin % | 22.9% | 18.3% | 23.2% | |||
| Free Cash Flow Margin % | 21.3% | 10.5% | 10.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.7B | +15.8% | $0.39 | $0.38–$0.40 | — | 3 |
| 2027 | $2.0B | +12.4% | $0.46 | $0.38–$0.50 | — | 4 |
| 2028 | $2.2B | +11.7% | $0.52 | $0.44–$0.55 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-26 | $0.20 | $0.20 | +3.9% |
| 2026-03-25 | $0.17 | $0.18 | +6.7% |
| 2025-08-27 | $0.15 | $0.15 | +0.0% |
| 2025-03-25 | $0.13 | $0.13 | +0.2% |
| 2024-08-29 | $0.13 | $0.13 | +4.6% |
| 2024-03-26 | $0.06 | $0.05 | -12.7% |
| 2023-08-22 | $0.12 | $0.13 | +12.5% |
| 2023-03-28 | $0.06 | $0.08 | +31.4% |
| $8.05 |
| +0.00% |
| $4.7B |
| — |
| 2190.HKZylox-Tonbridge Medical Technology Co., Ltd. | $20.44 | -1.35% | $6.4B | — |
| 2192.HKMedlive Technology Co., Ltd. | $6.80 | -1.87% | $5.0B | — |
Source: Financial Modeling Prep · peers by sector/industry